Lenskart outpaces Titan EyeCare on margins and store growth in India's eyewear market, resurfacing a late-October comparison
Resurfacing figures from late October: post-IPO, Lenskart posted 69.2% product margins and 19.8% Q2 EBITDA on Rs 2,146.6 crore revenue (up 24%), adding 203 net new stores across 431 cities. Titan EyeCare grew income to Rs 215 crore but saw segment EBIT halve to Rs 12 crore from Rs 24 crore.
What happened
Comparison of Lenskart and Titan EyeCare strategies post-Lenskart IPO. Lenskart shows stronger margins (69.2% product, 19.8% EBITDA) and faster store expansion,
Key facts
- listed at Rs 390
- issue price Rs 402
- market ~$9.2 billion
- Rs 30,000 crore market
- 9.3 million eye tests H1 FY26
- 203 net new stores
- 431 cities
- Q2 product margin 69.2%
- 35%-40% cost advantage
- Q2 revenue Rs 2,146.6 crore up 24%
- EBITDA Rs 425.8 crore at 19.8%
- H1 EBITDA margin 19.5% vs 17.3%
- Titan EyeCare income Rs 215 crore from Rs 199 crore
- Titan segment EBIT Rs 12 crore from Rs 24 crore
- 871 exclusive EyeCare stores
Why this matters
Titan EyeCare's eroding profitability against Lenskart's expanding margins and footprint opens the door to defensive M&A or partnership moves in India's fragmenting eyewear market.
What to watch
- Lenskart same-store sales growth vs new-store dilution in next 2 quarters
- Titan EyeCare EBIT trajectory — stabilization vs continued decline
- Lenskart post-IPO capex and free cash flow disclosures
- Competitive discounting intensity and customer acquisition cost trends
- New entrant or D2C eyewear brand traction in India
- Lenskart accelerates tier-2/tier-3 store rollout and own-brand/private-label lens penetration to defend margins
- Titan restructures EyeCare toward higher-margin premium eyewear and bundled optical services
- Both intensify eye-exam/omnichannel and subscription (contact lens) plays to raise repeat purchase frequency
- Lenskart deploys IPO proceeds into international expansion and manufacturing/vertical integration